» Articles » PMID: 38188058

From Cells to Insights: the Power of Human Pluripotent Stem Cell-derived Cortical Interneurons in Psychiatric Disorder Modeling

Overview
Specialty Psychiatry
Date 2024 Jan 8
PMID 38188058
Authors
Affiliations
Soon will be listed here.
Abstract

Psychiatric disorders, such as schizophrenia (SCZ) and autism spectrum disorders (ASD), represent a global health challenge with their poorly understood and complex etiologies. Cortical interneurons (cINs) are the primary inhibitory neurons in the cortex and their subtypes, especially those that are generated from the medial ganglionic emission (MGE) region, have been shown to play an important role in the pathogenesis of these psychiatric disorders. Recent advances in induced pluripotent stem cell (iPSC) technologies provide exciting opportunities to model and study these disorders using human iPSC-derived cINs. In this review, we present a comprehensive overview of various methods employed to generate MGE-type cINs from human iPSCs, which are mainly categorized into induction by signaling molecules vs. direct genetic manipulation. We discuss their advantages, limitations, and potential applications in psychiatric disorder modeling to aid researchers in choosing the appropriate methods based on their research goals. We also provide examples of how these methods have been applied to study the pathogenesis of psychiatric disorders. In addition, we discuss ongoing challenges and future directions in the field. Overall, iPSC-derived cINs provide a powerful tool to model the developmental pathogenesis of psychiatric disorders, thus aiding in uncovering disease mechanisms and potential therapeutic targets. This review article will provide valuable resources for researchers seeking to navigate the complexities of cIN generation methods and their applications in the study of psychiatric disorders.

Citing Articles

Overcoming Graft Rejection in Induced Pluripotent Stem Cell-Derived Inhibitory Interneurons for Drug-Resistant Epilepsy.

Beaudreault C, Wang R, Muh C, Rosenberg A, Funari A, McGoldrick P Brain Sci. 2024; 14(10).

PMID: 39452039 PMC: 11506040. DOI: 10.3390/brainsci14101027.

References
1.
Kaiser T, Feng G . Modeling psychiatric disorders for developing effective treatments. Nat Med. 2015; 21(9):979-88. PMC: 4886231. DOI: 10.1038/nm.3935. View

2.
Sharf T, van der Molen T, Glasauer S, Guzman E, Buccino A, Luna G . Functional neuronal circuitry and oscillatory dynamics in human brain organoids. Nat Commun. 2022; 13(1):4403. PMC: 9338020. DOI: 10.1038/s41467-022-32115-4. View

3.
Yuan F, Fang K, Cao S, Qu Z, Li Q, Krencik R . Efficient generation of region-specific forebrain neurons from human pluripotent stem cells under highly defined condition. Sci Rep. 2015; 5:18550. PMC: 4680876. DOI: 10.1038/srep18550. View

4.
Shi Y, Sun L, Wang M, Liu J, Zhong S, Li R . Vascularized human cortical organoids (vOrganoids) model cortical development in vivo. PLoS Biol. 2020; 18(5):e3000705. PMC: 7250475. DOI: 10.1371/journal.pbio.3000705. View

5.
Notaras M, Lodhi A, Dundar F, Collier P, Sayles N, Tilgner H . Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. Mol Psychiatry. 2021; 27(3):1416-1434. PMC: 9095467. DOI: 10.1038/s41380-021-01316-6. View